Here, we identified a PPP1R1B::STARD3 fusion transcript in a 12-year-old Iranian boy with AML by transcriptome analysis and confirmed it using q-PCR and Sanger sequencing, suggesting that it may be a novel biomarker in AML. This evidence concerns the gene STARD3 and acute myeloid leukemia.